Which hedge funds own PRME? PRIME MEDICINE INC, Q2 2026 13F holders
11 of the hedge funds tracked by WhaleCreep disclosed a position in PRME (PRIME MEDICINE INC) in their Q2 2026 13F filings, worth $44.0m in total. The largest holder by portfolio weight is Casdin Capital at 0.6% of its book. 3 managers opened a new position this quarter: Point72 Asset Management LP, Millennium Management, Brevan Howard Capital Management. 1 exited: Tudor Investment.
11tracked managers holding
3opened this quarter
1exited this quarter
Which hedge funds hold PRME? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Casdin Capital | Q2 2026 | 0.6% | $11.7m | 3,167,175 | 0% | held |
| Moore Capital Management | Q2 2026 | 0.0% | $1.8m | 500,000 | 0% | held |
| Woodline Partners | Q2 2026 | 0.0% | $11.1m | 3,003,904 | 0% | held |
| Farallon Capital Management | Q2 2026 | 0.0% | $4.6m | 1,240,843 | 0% | held |
| Citadel Advisors | Q2 2026 | 0.0% | $7.6m | 2,054,543 | 511% | added |
| Point72 Asset Management LP | Q2 2026 | 0.0% | $2.0m | 533,553 | – | new |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $2.4m | 648,940 | -53% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $1.6m | 427,097 | – | new |
| Marshall Wace | Q2 2026 | 0.0% | $800.1k | 216,841 | 53% | added |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $47.6k | 12,910 | – | new |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $433.2k | 117,412 | -84% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Tudor Investment | 0.0% | $214.2k |
How has hedge fund ownership of PRME changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 11 | $44.0m |
| Q1 2026 | 9 | $36.8m |
| Q4 2025 | 6 | $33.4m |
| Q3 2025 | 7 | $86.5m |
| Q2 2025 | 4 | $7.5m |
| Q1 2025 | 5 | $4.2m |
| Q4 2024 | 4 | $4.9m |
| Q3 2024 | 5 | $9.0m |
| Q2 2024 | 4 | $11.9m |
| Q1 2024 | 6 | $28.2m |
| Q4 2023 | 3 | $4.8m |
| Q3 2023 | 2 | $7.8m |
| Q2 2023 | 2 | $11.9m |
| Q1 2023 | 2 | $15.2m |
| Q4 2022 | 2 | $22.9m |
Counts every tracked manager that disclosed PRME in that quarter's filing, including managers that have since stopped filing.